BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/27/2026 8:10:54 AM | Browse: 2 | Download: 16
 |
Received |
|
2025-10-01 01:50 |
|
Peer-Review Started |
|
2025-10-01 01:50 |
|
First Decision by Editorial Office Director |
|
2025-10-11 03:30 |
|
Return for Revision |
|
2025-10-11 03:30 |
|
Revised |
|
2025-12-02 00:20 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-02-03 02:34 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-03 03:54 |
|
Articles in Press |
|
2026-02-03 03:54 |
|
Edit the Manuscript by Language Editor |
|
2026-02-10 22:17 |
|
Typeset the Manuscript |
|
2026-05-14 01:12 |
|
Publish the Manuscript Online |
|
2026-05-27 08:10 |
| ISSN |
2150-5349 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Prospective Study |
| Article Title |
Effect of cholecystectomy on liver fat and fibrosis in metabolic dysfunction-associated steatotic liver disease patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Khellaf Amalou, Nassila Belal, Abdelghani Tibouk, Yasmine Ghedada, Rym Rekab, Sabrina Fadel, Nabil Debzi and Abderezak Bousloub |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Khellaf Amalou, Assistant Professor, PhD, Department of Gastroenterology, Mohamed Seghir Nekkache, Kouba 246, Algiers 16000, Algeria. amalou_kh@yahoo.fr |
| Key Words |
Metabolic dysfunction-associated steatotic liver disease; Cholecystectomy; Hepatic fibrosis; Metabolic dysfunction-associated steatotic liver; Metabolic dysfunction-associated steatohepatitis |
| Core Tip |
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the most common chronic liver disease. It is significantly linked to diabetes, obesity, and other cardiometabolic risk factors. It is more pronounced in cholecystectomized patients than in those with lithiasis. Recent research suggests that the gallbladder may help to maintain overall metabolic homeostasis. Recent data suggests that cholecystectomy (Chx) has metabolic effects and may operate as a risk factor for MASLD and metabolic syndrome. In our study, we found that Chx enhances metabolic dysfunction-associated steatotic liver and fibrosis. MASLD prevalence is higher in the Chx group than in the general population. |
| Publish Date |
2026-05-27 08:10 |
| Citation |
Amalou K, Belal N, Tibouk A, Ghedada Y, Rekab R, Fadel S, Debzi N, Bousloub A. Effect of cholecystectomy on liver fat and fibrosis in metabolic dysfunction-associated steatotic liver disease patients. World J Gastrointest Pharmacol Ther 2026; 17(2): 114876
|
| URL |
https://www.wjgnet.com/2150-5349/full/v17/i2/114876.htm |
| DOI |
https://dx.doi.org/10.4292/wjgpt.v17.i2.114876 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
